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Abstract 
Microorganism involvement in cancer has been identified for over a century, and different types of bacteria have been 
associated with carcinogenesis. Philenoptera violacea (Klotzsch) Schrire and Xanthocercis zambesiaca (Baker) Dumaz-le-
Grand plant extracts are traditionally used by South African traditional healers for the treatment of inflammation related 
disorders; however, their efficacy has not been determined. The aim of this study was to investigate the antimicrobial activity 
of the mixture of leaves, flower & twig of each plant extract respectively. Antimicrobial activity was determined using p-
Iodonitrotetrazolium chloride (INT) assay on gram-positive bacterium: Staphylococcus aureus, S. epidermidis, S. saprohyticus, 
Bacillus subtilis, and gram-negative bacterium: Enterobacter cloacae, Escherichia coli, Pseudomonas aeruginosa. Results of 
antimicrobial activity revealed that both plant extracts had no antimicrobial activity against selected micro-organisms. Thus, 
we couldn’t support or confirm the antimicrobial activity potential of these plants as reported by traditional healers, however, 
factors that might have contributed to these results were not excluded. 
Key words: Philenoptera violacea, Xanthocercis zambesiaca, Antimicrobial activity, p-Iodonitrotetrazolium chloride (INT) assay, 
cancer 
INTRODUCTION 
African populations are faced with a challenge of 
chronic diseases emergence whose treatment and follow-up 
creates a major economic problem for them[1]. Of all the 
alternative modalities, herbal medicine is probably the most 
popular and the most ubiquitous[2] as it is easily accessible 
and less expensive. The World Health Organization has 
described traditional herbal medicine as one of the surest 
means to achieve total health care coverage of the world’s 
population[3]. In traditional herbal practice in Africa, 
indigenous medicinal plants have been employed in the 
treatment of several important infections[4]. Interest in 
medicinal plant research has escalated, with the aim of 
identifying alternative antimicrobial therapies to overcome 
resistance[5].  
Traditional medicinal practices are used to treat a 
variety of diseases including skin disorders, tuberculosis, 
urinary tract infections and gastrointestinal disorders etc[6]. 
Microorganism involvement in cancer has been identified 
for over a century, and different types of bacteria have been 
associated with carcinogenesis. Staphylococcus aureus is 
considered as the first bacterium to be described as a 
cancer-producing agent, and some authors have attempted 
to associate it with breast cancer [7,8]. Gram-negative 
pathogens, such as Escherichia coli have been identified in 
the prostate, and their toxins are responsible for the 
inflammatory response. Inflammation should be considered 
a new domain in basic and clinical research in patients with 
prostate cancer and benign prostatic hyperplasia (BPH). 
Bacterial infections, urine reflux, dietary factors, hormones, 
and autoimmune response have been considered to cause 
inflammation in the prostate[9].  
From a pathophysiologic point of view, tissue damage 
associated with inflammatory response and subsequent 
chronic tissue healing may result in the development of 
BPH nodules and proliferative inflammatory atrophy (PIA). 
BPH, benefit from antimicrobial and anti-inflammatory 
treatment. Moreover, the inflammatory microenvironment 
favours the survival and proliferation of neoplastic cells 
[10,11], thus indicating that the modulation of factors fuelling 
chronic inflammation may have anticancer effects. 
Therefore this study was performed with an aim of 
determining the antimicrobial activities of Philenoptera 
violacea (Klotzsch) Schrire and Xanthocercis zambesiaca 
(Baker) Dumaz-le-Grand (to be referred to as P.violacea 
and X.zambesiaca in this research report). 
METHODOLOGY 
Plant material 
The plant materials, P.violacea and X.zambesiaca were 
authenticated, collected and extracted by scientists at the 
University of Free State in Bloemfontein, South Africa. 
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These two plants were randomly chosen from 60 plants 
belonging to the Fabaceae family which are used by South 
African traditional healers for the treatment of different 
health ailments. Twigs, leaves and flowers of P.violacea 
and X.zambesiaca were collected and mixed 
respectively.The collected materials were dried at room 
temperature and pulverized by mechanical mills and 
weighed. It was then stored in a cool place until analysis.  
Sterilization 
Petri dishes, beakers, McCartney bottles, pipette, test 
tubes, filter papers and other metal apparatus such as 
spatula and forceps were sterilized using hot air oven at a 
temperature of 1600C for 1 hour. The wire loops were 
sterilized by heating on the blue flame of the Bunsen burner 
until red-hot and allowed to cool and 70% alcohol was used 
to swab/clean the work bench area to prevent 
contamination. The process was carried out aseptically. 
Extraction method 
Plant extracts were dissolved in DMSO at stock 
concentrations of 100 mg/mL.  Working concentrations of 
4 mg/mL were prepared in MH broth. 
Microorganisms, growth conditions and media  
Staphylococcus aureus, S. epidermidis, S. 
saprohyticus, Bacillus subtilis, Enterobacter cloacae, 
Escherichia coli and Pseudomonas aeruginosa (clinical 
strains) were grown in Mueller-Hinton (MH) broth 
(Merck).  One microorganism colony was inoculated in the 
broth and allowed to grow for 16 h (log growth phase) at 
370C in an orbital shaker (150 rpm).  
Control drugs: Imipenem monohydrate (Sigma) and 
ampicillin sodium salt (Calbiochem)/doxycycline hyclate 
(Sigma) were used as positive controls against Gram-
negative bacteria and Gram-positive bacteria, respectively.  
Antibiotics were dissolved in MH broth at stock 
concentrations of 2 mg/mL and filter sterilized (0.2 µM 
filter).  Working concentrations of 64 µg/mL imipenem and 
16 µg/mL ampicillin and doxycyline were prepared in MH 
broth. 
 
 
 
Microbroth dilution method  
MH broth (50 µL) was added to all test wells (i.e. plant 
extracts and antibiotics), accept to the highest plant extract 
and antibiotic concentration wells to which 100 µL of the 
working concentrations were added.  Serial dilutions were 
prepared for the plant extracts (2 mg/mL to 125 µg/mL) 
and antibiotic (32-0.125 µg/mL and 8-0.016 µg/mL for 
imipenem and ampicillin/doxycycline, respectively).  The 
cultures were assessed and adjusted to a 0.5 McFarland 
standard (absorbance at 600 nm = 0.08-0.1; equivalent to 
~1.5x108 cells/mL) and 50 µL added to each test well.  The 
following controls were prepared: (i) antibiotic/medium 
control (50 µL MH broth + 50 µL of highest 
antibiotic/fluconazole concentration); (ii) plant extract 
colour control (50 µL MH broth + 50 µL of highest plant 
extract concentration); (iii) 2% DMSO control (50 µL MH 
broth + 50 µL 4% DMSO); and (iv) microorganism control 
(50 µL MH broth + 50 µL microorganism).  Plates were 
sealed with microplate sealing tape and incubated at 370C 
for 24 h.  
p-Iodonitrotetrazolium chloride (INT) assay   
After the incubation period, the absorbance of wells 
was read at 600 nm.  2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-
phenyltetrazolium chloride (INT, Sigma) was prepared at a 
working concentration of 0.2 mg/mL in distilled water and 
filtered (0.2 µM filter).  INT (20 µL) was added to each 
well and the plates were further incubated for 30-60 min at 
370C until there was a colour change.  The absorbance of 
wells was read at 600 nm.  Viable cells reduce the yellow 
dye to a pink/purple colour, whereas no colour change 
indicated inhibition of bacterial growth. 
Statistical analysis  
Tests were carried out in triplicates. MIC of test 
samples was compared with that of positive and negative 
controls. The mean values were calculated from the 
triplicate values. Absorbance values were expressed as the 
Mean ± SD (n=3).  
 
 
RESULTS 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 
control 1 control 3 B 2 B 1 B 0.5 B 0.25 B 0.125 C 2 C 1 C 0.5 C 0.25 C 0.125 
B 
C 
D 
E 
control 2 control 4 control 5 AB 32 AB 16 AB 8 AB 4 AB 2 AB 1 AB 0.5 AB 0.25 AB 0.125 
F 
G 
H 
Table 1: Microplates template 
 
control 1 = 50 uL medium and 50 uL 32 ug/mL antibiotic, control 2 = 50 uL medium and 50 uL 2 mg/mL extract B; no 
microorganism (colour control), control 3 = 50 uL medium and 50 uL 2mg/mL extract C; no microorganism (colour 
control), control 4 = 50 uL 2% DMSO and 50 uL microorganism, control 5 = 50 uL medium and 50 uL microorganism. 
AB = Positive control; B = P. violacea plant extracts; C= X. zambesiaca plant extracts 
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Concentration B C AB 
2 mg/ml 0.724 ±0.01 0.722 ±0.01 0.056 ±0.01 
1 mg/ml 0.641 ±0.03 0.754 ±0.05 0.074 ±0.01 
0.5 mg/ml 0.691 ±0.05 0.735 ±0.02 0.050 ±0.01 
0.25 mg/ml 0.574 ±0.04 0.677 ±0.07 0.043 ±0.01 
0.125 mg/ml 0.514 ±0.06 0.700 ±0.02 0.047 ±0.01 
Table 2: OD600 nm readings after INT was added 
 
 
Figure 1:  Photos of the INT plates 
 
Microorganism Positive control MIC 
Bacillus subtilis Imipenem 4-8 µg/mL 
Enterobacter cloacae Imipenem 16 µg/mL 
Escherichia coli Imipenem 16-32 µg/mL 
Pseudomonas 
aeruginosa Imipenem 32 µg/mL 
Staphylococcus aureus Ampicillin/doxycycline 0.5-1 µg/mL 
Staphylococcus 
epidermidis Ampicillin/doxycycline 
0.125-2 
µg/mL 
Staphylococcus 
saprophyticus Ampicillin/doxycycline 1-2 µg/mL 
Table 3. MIC values of antibiotics used 
 
Table 1 illustrates the setup of the microplates used for this 
assay. Absorbance readings of 96-well plates were taken at 
a wavelength of 600 nm before and after INT addition. The 
absorbance after INT was added was greater (>1.00) for 
both plant extracts when compared to that of the positive 
control (table 2) as a result of microbial growth even at the 
highest concentration of 2 mg/ml. Therefore, MIC couldn’t 
be determined and the percentage inhibition for the plant 
extracts was also not calculated as there was no observable 
inhibition of microbial growth (figure 1). For the Gram-
positive bacteria (i.e. S. aureus, S. epidermidis and S. 
saprophyticus) imipenem was initially used as a positive 
control, but it caused complete inhibition even at the lowest 
concentration (0.125 µg/mL). Ampicillin and doxycyline 
were used to determine MIC values for the Gram-positive 
bacteria (Table 3). 
 
DISCUSSION 
Natural products have played a vital role in the 
discovery of antimicrobial drugs, with the drug either being 
completely derived from the natural product, or serving as a 
lead for novel drug discovery. Plants synthesise a diverse 
array of compounds (secondary metabolites) which play a 
key role in the natural defence mechanism. These aromatic 
compounds have been found to be useful antimicrobial 
phytochemicals and, as a result, these compounds are now 
divided into different chemical categories: phenolics, 
terpenoids and essential oils, alkaloids, lectins and 
polypeptides, as well as polyacetylenes[12]. 
Fluoroquinolones were presented as a totally synthetic, 
significant class of antibiotics in the 1990’s [13]. Some 
examples of naturally occurring antimicrobials which are 
used currently include drug classes such as the penicillins 
and cephalosporins (β-lactam being the empirically active 
component). An increase in the isolation and identification 
of antimicrobial compounds may contribute greatly to the 
success in antibiotic discovery. 
The efficacy of an antimicrobial agent can be 
estimated through the determination of the minimum 
inhibitory concentration (MIC), being the minimum 
concentration at which no microbial growth occurs after a 
specified exposure time to the antimicrobial agent[14]. There 
are numerous methods for the screening of biological 
extracts for potential antimicrobial activity. The microbroth 
dilution susceptibility method in 96 well microtiter plates 
has become the preferred method for drug susceptibility 
testing because it has small sample requirements, cost 
effective and a high-throughput rate[15]. The p-
Iodonitrotetrazolium chloride (INT) assay is a microplate 
assay that determines the minimum inhibitory 
concentration (MIC) of biological extracts using INT dye. 
This dye acts as an electron acceptor and is reduced by 
viable bacteria to produce a coloured product. The yellow 
tetrazolium dye is reduced by viable microorganisms to a 
pink/purple colour. The MIC, for the INT assay, is defined 
as the lowest extract concentration that exhibits complete 
bacterial growth inhibition and prevents the dye from 
changing colour [16]. 
The ideal chemotherapeutic agent has a high 
therapeutic index with selective toxicity to cause damage to 
pathogens without causing similar harmful effects to its 
eukaryotic host[17]. This lethal damage to pathogens might 
be through the inhibition of cell wall synthesis, protein 
synthesis or nucleic acid synthesis, as well as through the 
disruption of the cell membrane and the inhibition of 
certain essential enzymes. This results in selective 
disruption of the specific structure and/or function essential 
to bacterial growth and survival[14]. However, there are 
factors that can influence efficacy of antimicrobial agent 
such as the ability of the drug to reach the target site of 
infection and the susceptibility of the pathogen to the 
particular chemotherapeutic agent. Nonpolar or lipophilic 
extracts are known to not easily diffuse into agar. The 
differences in solubility, volatility, and diffusion 
characteristics are among the factors that affect the 
antimicrobial potency of medicinal plant extracts[18].  
X. zambesiaca is used by traditional healers in 
Limpopo (South Africa) for treatment of symptoms such as 
wounds, boils, purulent sores and diarrhea[19]. A study by 
Masoko (2013) reported good antimicrobial activity of 
leaves of X. zambesiaca with methanol, using a microplate 
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serial dilution technique with Staphylococcus aureus, 
Pseudomonas aeruginosa, Escherichia coli and 
Enterococcus faecalis as test organisms[19]. P.violacea is 
reported to be used in traditional remedies to treat gastro-
intestinal problems, powdered root-bark for colds and 
snakebite treatment, root infusions as hookworm remedy 
and most part of the plant has been used to treat 
diarrhoea[20]. Antimicrobial activity of P. violacea and X.  
zambesiaca plant extracts was determined using INT assay 
against selected Gram positive and Gram negative 
bacterium that contributes to carcinogenesis. From our 
results, both plant extracts showed no antimicrobial activity 
against S. epidermidis, S. saprohyticus, Bacillus subtilis, 
Enterobacter cloacae and also against bacteria tested on by 
Masoko (2013) such as Pseudomonas aeruginosa, 
Staphylococcus aureus, Escherichia coli[19]. These results 
were not expected, as it has been reported previously that 
X. zambesiaca leaves had antimicrobial activity against
Gram-negative and Gram-positive bacteria[19].
Weak microbial inhibitors are classified as those 
agents with MIC values greater than the ranges listed in 
Table 3. The sensitivity of Staphylococcus aureus, S. 
epidermidis, S. saprohyticus, Bacillus subtilis, 
Enterobacter cloacae, Escherichia coli and Pseudomonas 
aeruginosa with respect to P. violacea and X. zambesiaca 
plant extracts was similar, indicating poor antimicrobial 
activity. However, in our study, we mixed different part of 
the plant: leaves, twigs and flowers of the plants 
respectively. Thus there is a possibility of other compounds 
from twig and flowers suppressing the activity of active 
antimicrobial compounds from the leaves of our plant 
extracts instead of having a synergetic effect. There are also 
a number of factors which might contribute to these 
outcomes such as the area where the plants are collected 
and climate changes. The other factor might be the 
preparation of treatment by traditional healers as sometimes 
they prepare treatment using more than one plant and there 
is no systematic approach in doing that. The solvent used to 
extract also contributed to our results as traditional healers 
use other solvents such as water and different extraction 
method such as boiling. 
CONCLUSION 
To conclude, the results of this study showed that both 
X. zambesiaca and P. violacea plant extracts had no
antimicrobial activity against S. epidermidis, S.
saprohyticus, Bacillus subtilis, E. cloacae, P. aeruginosa,
S. aureus and E. coli. We therefore couldn’t support or
confirm the antimicrobial activity potential of these plants
as reported by traditional healers, however, factors that
might have contributed to these results are not excluded.
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